Lipidomic Profiling of Sinus Mucosa from Patients with Chronic Rhinosinusitis. Issue 2 (15th January 2015)

• Record Type: Journal Article
• Authors: Fazlollahi, Farbod; Kongmanas, Kessiri; Tanphaichitr, Nongnuj; Clair, Jon Mallen‐St.; Gopen, Quinton; Faull, Kym F.; Suh, Jeffrey D.
• Is Part Of: Clinical and translational science. Volume 8:Issue 2(2015)
• Page Start: 107
• Page End: 115
• Publication Date: 2015-01-15
• Subjects: metabolism -- lipids -- fatty acids -- polyps -- tissue; Medicine, Experimental -- Periodicals; Medical innovations -- Periodicals; 616.027
• DOI: 10.1111/cts.12256
• Languages: English
• ISSNs: 1752-8054

Abstract

Abstract: Sinusitis is a cause of significant morbidity, substantial healthcare costs, and negative effects on quality of life. The primary objective of this study is to characterize the previously unknown lipid profile of sinonasal mucosa from patients with chronic rhinosinusitis (CRS) and from controls. Sinus mucosa samples were analyzed from 9 CRS patients with concomitant nasal polyps, 11 CRS patients without polyps, and 12 controls. Ten lone polyp samples were also analyzed. Samples were subjected to a modified Bligh/Dyer lipid extraction, then high performance thin layer chromatography (HPTLC), combined gas chromatography/electron impact‐mass spectrometry (GC/EI‐MS), and flow‐injection/electrospray ionization‐tandem mass spectrometry (FI/ESI‐MS/MS). Data was analyzed for identification and profiling of major components. HPTLC revealed an array of species reflecting the lipid complexity of the samples. GC/EI‐MS revealed cholesterol and several fatty acids. FI/ESI‐MSMS revealed numerous lipid species, namely a host of phosphatidylcholines, phosphatidylethanolamines, ceramides and cholesteryl esters, but no detectable amounts of phosphatidyinositols or sulfated lipids. These results are a first step to uncover unique molecular biomarkers in CRS.